Researchers at the University of Louisville School of Medicine are using breath analysis to detect the presence of lung cancer.
Preliminary data indicate that this promising noninvasive tool offers the sensitivity of PET scanning, and has almost twice the specificity of PET for distinguishing patients with benign lung disease from those with early stage cancer. Michael Bousamra II, MD, Associate Professor, Department of Cardiovascular and Thoracic Surgery, is presenting the results of the study at the AATS 2014 Conference on April 29, 2014.
A reliable, noninvasive diagnostic method imposes less physical and financial burden on patients who actually have no significant disease, while rapid and accurate diagnosis expedites treatment for patients who truly have lung cancer.
The team believes that while the breath test would not replace CT as a primary screening tool, it would be particularly helpful in conjunction with a positive CT scan result. “This breath analysis method presents the potential for a cheaper and more reliable diagnostic option for patients found to have bulky disease on a CT scan. If the breath analysis is negative, the patient may, in some instances, be followed with repeated exams without necessitating a biopsy. But a positive breath analysis would indicate that the patient may proceed to definitive biopsy, thus expediting treatment,” says Dr. Bousamra.
Investigators used specially coated silicon microchips to collect breath samples from 88 healthy controls, 107 patients with lung cancer, 40 individuals with benign pulmonary disease, and 7 with metastatic lung cancer.
Previous work had pinpointed four specific substances, known as carbonyl compounds, in breath samples as “elevated cancer markers” (ECMs) that distinguish patients with lung cancer from those with benign disease. The carbonyl compounds found in the breath are thought to reflect chemical reactions occurring in malignant lung tumors. In this study, the authors compared the findings from the breath analyses to the results from PET scans.
The investigators found that the sensitivity and specificity of breath analysis depended upon how many of the ECMs were elevated. For example, having 3 or 4 ECMs was diagnostic of lung cancer in 95% of those with this result. The majority of patients with benign pulmonary disease had either 0 or 1 ECM, while those with Stage IV cancer were most likely to have 3 or 4. The number of ECMs could be used to differentiate benign disease from both early and advanced stage lung cancer. Interestingly, 3 of the 4 elevated markers returned to normal levels after cancer resection.
When it comes to differentiating early stage lung cancer from benign pulmonary disease, breath analysis and PET scanning had similar sensitivities (82.8% and 90.3%, respectively). However, breath analysis had a much higher specificity than PET (75% vs. 38.7%, respectively) for distinguishing benign disease, which means that it was much more accurate at identifying those who did not have cancer. This would be an important feature for patients with benign disease, since having a breath analysis rather than PET scan could mean avoiding an unnecessary invasive biopsy procedure later on.
The Latest on: Detect Early Lung Cancer
[google_news title=”” keyword=”Detect Early Lung Cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Detect Early Lung Cancer
- Study shows the enduring impact of historical redlining on colon cancer careon March 28, 2024 at 8:33 pm
A nationwide study of 196 cities shows that housing discrimination from 90 years ago still casts a historical shadow of inequities in colon cancer care today, S.M. Qasim Hussaini, M.D., of the ...
- Wellness Wednesday: Lung Cancer Detectionon March 27, 2024 at 3:07 pm
Mercy Medical Center in Redding is the only location between Sacramento and Portland offering this life-saving procedure using what they call the Ion Robotic Lung Program.
- Navigating Lung Cancer: 5 Essential Facts Families Should Know About Lung Nodules and Stagingon March 27, 2024 at 3:02 am
Lung Association and Olympus team up on new educational campaign to demystify lung cancer nodules, staging and improve treatment ...
- Sparrow robotic surgery helps diagnose early stages of lung canceron March 26, 2024 at 10:50 pm
Sparrow Hospital is offering a new robotic surgery to diagnose and treat the early stages of lung cancer. It’s a potentially life-saving procedure, combining both robotic bronchoscopy and thoracic ...
- Sparrow doctors find new way to tackle lung cancer with robotic helpon March 26, 2024 at 9:16 pm
Sparrow doctors are combining techniques and procedures to give lung cancer patients an advantage in fighting the disease.
- Early Detection May Help Kentucky Tamp Down Its Lung Cancer Crisison March 25, 2024 at 2:00 pm
Lung cancer death rates are worst in a swath of states including Kentucky and its neighbors Tennessee and West Virginia.
- Redefining lung cancer care with early intervention and personalized treatmenton March 22, 2024 at 1:22 pm
This year’s Philippine National Cancer Summit brought together a diverse range of stakeholders from the national and international cancer communities to address critical challenges under the theme ...
- LungVax: Finally a vaccine that could stop lung cancer?on March 22, 2024 at 3:08 am
The two-year project has received significant funding of £1.7 million (roughly $ 2.1 million) for laboratory research and the initial trial 3,000 doses.
- ‘Here’s How I Knew I Had Lung Cancer’: One Patient’s Story with Relatively Low Risk Factoron March 21, 2024 at 2:11 pm
One patient shares how he knew he had lung cancer—says one expert doctor: "All you need to be at risk of developing lung cancer is a lung." ...
- Study discusses liquid biopsy as a game changer for early lung cancer detectionon March 20, 2024 at 1:43 pm
In 2020, 1.8 million people succumbed to lung cancer. The late-stage discovery of lung cancer is one of the glaring challenges faced by the medical community. While surgical biopsies continue to ...
via Bing News